St. Traweek et al., DETECTION OF MYELOPEROXIDASE GENE-EXPRESSION IN MINIMALLY DIFFERENTIATED ACUTE MYELOGENOUS LEUKEMIA (AML-M0) USING IN-SITU HYBRIDIZATION, Diagnostic molecular pathology, 4(3), 1995, pp. 212-219
Acute leukemias containing >3% myeloperoxidase (MPO)-positive blast ce
lls, as detected cytochemically, are considered to be myelogenous in o
rigin, regardless of the immunophenotypic markers expressed. Conversel
y, acute leukemias that express only myeloid antigens are also conside
red to be acute myelogenous leukemia (AML), even in the absence of MPO
. These MPO-negative AMLs, designated AML-M0 in the FAB classification
, currently require either immunophenotypic or electron microscopic st
udies for identification. To examine the association of MPO and myeloi
d antigen expression in AML, particularly at the early stages of myelo
id cell differentiation, we have used in situ hybridization (ISH) to e
valuate MPO gene expression in myeloid leukemia cell lines and a varie
ty of well-characterized acute leukemias, including six cases of AML-M
0. Strong positivity for MPO mRNA was detected in the myeloid leukemia
cell line HL-60 and in 22 of 27 AMLs (three AML-M0, four AML-M1, eigh
t AML-M2, five AML-M4, two AML-M5a). No MPO gene expression was detect
ed in three AML-M0, one AML-M5a, one AML-M7, 5 acute lymphoblastic leu
kemia, the lymphoid cell lines Molt-4 and Namalwa, or in the early mye
loid cell lines KG-1 and KG-1a. Ultrastructural studies for MPO activi
ty were performed on four AML-M0; one leukemia showed both gene expres
sion and cytochemical activity, whereas two others contained neither M
PO transcripts nor enzyme. Weak MPO gene expression was evident in one
AML-M0 that was negative for enzymatic activity by electron microscop
y. These studies show that MPO gene expression can be detected by ISH
in about half of AML-M0, supporting their presumed myelocytic derivati
on. However, the blasts in some AML-M0 fail to express MPO, even at th
e molecular level, suggesting that these cells are at a very early sta
ge of myeloid commitment or that differentiation along some other nonl
ymphoid cell line may be present.